← Back to DCF

Breakdown · AZN.L

AstraZeneca

WACC
FCF PROJECTION
SENSITIVITY
PER-YEAR CASH FLOWS
Year CF Discount factor PV Cumulative PV
1 382.84 0.9355 358.15 358.15
2 406.60 0.8752 355.85 713.99
3 431.84 0.8187 353.56 1067.55
4 458.64 0.7659 351.29 1418.84
5 487.11 0.7165 349.03 1767.86
6 517.35 0.6703 346.78 2114.65
7 549.46 0.6271 344.55 2459.20
8 583.57 0.5866 342.34 2801.54
9 619.79 0.5488 340.14 3141.68
10 658.26 0.5134 337.95 3479.63
11 674.72 0.4803 324.06 3803.69
12 691.58 0.4493 310.74 4114.43
13 708.87 0.4203 297.97 4412.40
14 726.60 0.3932 285.72 4698.12
15 744.76 0.3679 273.97 4972.09
16 763.38 0.3441 262.71 5234.80
17 782.46 0.3219 251.91 5486.71
18 802.03 0.3012 241.55 5728.26
19 822.08 0.2818 231.62 5959.88
20 842.63 0.2636 222.10 6181.99
REVERSE DCF

At $13066.00, the market implies a stage-1 growth rate of 16.8%.

MARKET IMPLIES
16.8%
YOUR ASSUMPTION
6.2%
DELTA
+10.6pp

If $13066.00 is correct and your other inputs (WACC 6.9%, 10+10y, terminal 2.5%) hold, the market needs AZN.L to grow cash flow at 16.8% annually for the next 10 years.